Richard G. Thompson

3.1k citations

24 papers · 2.6k indexed · 1 hit paper · h-index 16

Immunology top 1%
Oncology top 2%
Molecular Biology
Cancer Research top 5%
Radiology, Nuclear Medicine and Imaging top 10%

Co-authors: Frances R. Balkwill Stephen C. Robinson Hagen Kulbe Thorsten Hagemann Kellie A. Charles Toby Lawrence Kate A Scott Robert J. Moore
Topics: Immune Cell Function and Interaction (5 papers)Immune cells in cancer (4 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)
Cited by: Immunology Oncology Cancer Research
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Investigation The Journal of Experimental Medicine
Partner nations: United Kingdom United States France

In The Last Decade

Richard G. Thompson

24 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

“Re-educating” tumor-associated macrophages by targeting NF-κB

2008 654 citations Thorsten Hagemann, Toby Lawrence et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Richard G. Thompson

Since Specialization

Citations

This map shows the geographic impact of Richard G. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard G. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard G. Thompson more than expected).

Fields of papers citing papers by Richard G. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard G. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard G. Thompson. The network helps show where Richard G. Thompson may publish in the future.

Co-authorship network of co-authors of Richard G. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Richard G. Thompson. A scholar is included among the top collaborators of Richard G. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard G. Thompson. Richard G. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cells 2016 ·Oncotarget ·Hagen Kulbe,Francesco Iorio,Probir Chakravarty,Carla Milagre,Robert J. Moore,Richard G. Thompson,(unknown),(unknown),(unknown),Denis Drygin,Elena Ioana Braicu,Jalid Sehouli,Julio Sáez-Rodríguez,Pedro R. Cutillas,Frances R. Balkwill	13
2	Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer 2015 ·Cancer Research ·Carla Milagre,Ganga Gopinathan,(unknown),Richard G. Thompson,Hagen Kulbe,Haihong Zhong,Robert E. Hollingsworth,Richard Grose,David D.L. Bowtell,Daniel Hochhauser,Frances R. Balkwill	36
3	Murine CD27 ⁽⁻⁾ Vγ6 ⁽⁺⁾ γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages 2014 ·Proceedings of the National Academy of Sciences ·Margarida Rei,Natacha Gonçalves‐Sousa,Telma Lança,Richard G. Thompson,Sofia Mensurado,Frances R. Balkwill,Hagen Kulbe,Daniel J. Pennington,Bruno Silva‐Santos	170
4	A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment 2011 ·Cancer Research ·Hagen Kulbe,Probir Chakravarty,David A. Leinster,Kellie A. Charles,Joseph Kwong,Richard G. Thompson,Jermaine Coward,Tiziana Schioppa,Stephen C. Robinson,William M. Gallagher,Laura Galletta,Michael A. Salako,John F. Smyth,Thorsten Hagemann,Donal J. Brennan,David D.L. Bowtell,Frances R. Balkwill	171
5	B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis 2011 ·Proceedings of the National Academy of Sciences ·Tiziana Schioppa,Robert J. Moore,Richard G. Thompson,Elizabeth C. Rosser,Hagen Kulbe,Sergei A. Nedospasov,Claudia Mauri,Lisa M. Coussens,Frances R. Balkwill	256
6	The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans 2009 ·Journal of Clinical Investigation ·Kellie A. Charles,Hagen Kulbe,Robin Soper,Monica Wang,Toby Lawrence,Anne M. Schultheis,Probir Chakravarty,Richard G. Thompson,George Kollias,John F. Smyth,Frances R. Balkwill,Thorsten Hagemann	270
7	“Re-educating” tumor-associated macrophages by targeting NF-κBbreakdown → 2008 ·The Journal of Experimental Medicine ·Thorsten Hagemann,Toby Lawrence,Iain A. McNeish,Kellie A. Charles,Hagen Kulbe,Richard G. Thompson,Stephen C. Robinson,Frances R. Balkwill	654
8	IgE-Antibody-Dependent Immunotherapy of Solid Tumors: Cytotoxic and Phagocytic Mechanisms of Eradication of Ovarian Cancer Cells 2007 ·The Journal of Immunology ·Sophia N. Karagiannis,Marguerite Bracher,James Hunt,Natalie McCloskey,Rebecca L. Beavil,Andrew J. Beavil,David J. Fear,Richard G. Thompson,(unknown),Frances Burke,Robert J. Moore,David Dombrowicz,Frances R. Balkwill,Hannah J. Gould	74
9	Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells 2007 ·Cancer Immunology Immunotherapy ·Sophia N. Karagiannis,Marguerite Bracher,Rebecca L. Beavil,Andrew J. Beavil,James Hunt,Natalie McCloskey,Richard G. Thompson,(unknown),Frances Burke,Brian J. Sutton,David Dombrowicz,Frances R. Balkwill,Hannah J. Gould	48
10	TNF-α regulates epithelial expression of MMP-9 and integrin αvβ6 during tumour promotion. A role for TNF-α in keratinocyte migration? 2004 ·Oncogene ·Kate A Scott,Caroline H. Arnott,Stephen C. Robinson,Robert J. Moore,Richard G. Thompson,John F. Marshall,Frances R. Balkwill	79
11	Activity of human monocytes in IgE antibody‐dependent surveillance and killing of ovarian tumor cells 2003 ·European Journal of Immunology ·Sophia N. Karagiannis,Qin Wang,N East,Frances Burke,(unknown),Marguerite Bracher,Richard G. Thompson,Stephen R. Durham,Lawrence B. Schwartz,Frances R. Balkwill,Hannah J. Gould	86
12	Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development 2003 ·Oncogene ·Caroline H. Arnott,Kate A Scott,Robert J. Moore,Stephen C. Robinson,Richard G. Thompson,Frances R. Balkwill	159
13	A chemokine receptor antagonist inhibits experimental breast tumor growth. 2003 ·PubMed ·Stephen C. Robinson,Kate A Scott,Julia L. Wilson,Richard G. Thompson,Amanda E. I. Proudfoot,Frances R. Balkwill	215
14	An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors. 2003 ·PubMed ·Kate A Scott,Robert J. Moore,Caroline H. Arnott,N East,Richard G. Thompson,Bernard J. Scallon,David J. Shealy,Frances R. Balkwill	131
15	Stability of ferrous hydroxide in aqueous suspension at 300°c 1967 ·Journal of Applied Chemistry ·J. E. Castle,Richard G. Thompson	6
16	Some analytical implications of the interaction between the water and oxygen permeabilities of polymers 1965 ·Journal of Applied Chemistry ·(unknown),E. C. Potter,Richard G. Thompson	1
17	Tromethamine (Talatrol) for Acidosis Therapy in Surgery 1963 ·Surgical Clinics of North America ·Richard G. Thompson,Peter V. Moulder,Robert W. Harrison,George R. Daicoff	9
18	PULMONARY ARTERIAL HYPEROXIA PRODUCING INCREASED PULMONARY VASCULAR RESISTANCE 1960 ·Journal of Thoracic and Cardiovascular Surgery ·Peter V. Moulder,Joseph R. Lancaster,Robert W. Harrison,(unknown),Mark E. Snyder,Richard G. Thompson	7
19	CARDIAC SURGERY WITH HYPOTHERMIA AND ACETYLCHOLINE ARREST 1956 ·Journal of Thoracic Surgery ·Peter V. Moulder,Richard G. Thompson,Curtis A. Smith,(unknown),William E. Adams	32
20	USE OF THE RECORDING OXIMETER IN MANAGEMENT OF POSTOPERATIVE OXYGEN THERAPY 1955 ·Journal of Thoracic Surgery ·(unknown),Richard G. Thompson,William E. Adams,J. F. Perkins,(unknown)	1

About Richard G. Thompson

Richard G. Thompson is a scholar working on Immunology, Immunology and Allergy and Cancer Research, having authored 24 papers that have together received 2.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), Immune cells in cancer (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Immunology (1.7k citations), Oncology (1.0k citations) and Cancer Research (416 citations). Richard G. Thompson has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Frances R. Balkwill, Stephen C. Robinson, Hagen Kulbe, Thorsten Hagemann, Kellie A. Charles, Toby Lawrence, Kate A Scott, Robert J. Moore, Iain A. McNeish and Caroline H. Arnott. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact